Up-regulation of clusterin (sulfated glycoprotein-2) in pancreatic islet cells upon streptozotocin injection to rats

I. S. Park, Y. Z. Che, M. Bendayan, S. W. Kang, Bon Hong Min

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Clusterin is a heterodimeric glycoprotein which has been shown to play important roles in programmed cell death and/or in tissue reorganization not only during embryonic development but also in damaged tissues. Recently, we reported the transient induction of clusterin in pancreatic endocrine cells during early developmental stages of islet formation. In the present study, we have investigated the expression of clusterin in pancreatic tissue of streptozotocin-treated rats which were undergoing extensive islet tissue reorganization due to degeneration of insulin β cells. Clusterin was found in endocrine cells identified as glucagon-secreting α cells at the periphery of the islet. Using immunoelectron microscopy, clusterin-positive cells showed the typical ultrastructural features of pancreatic α cells. In addition, colocalization of clusterin and glucagon in the same secretory granules was shown by double immunogold labeling. These results imply that clusterin is a secretory molecule having endocrine and/or paracrine actions in parallel with glucagon. Further, we noted that clusterin expression was increased in pancreatic α cells during the process of β cell death upon streptozotocin injection. The increase was significant as early as 1-3 h after streptozotocin treatment prior to any morphological alteration of islet β cell and any manifestation of hyperglycemia. The expression of clusterin was steady-stately up-regulated during the process of islet reorganization caused by streptozotocin-induced cytotoxic injury. Therefore, we suggest that clusterin might be considered as a molecule induced by both embryonic development and drug-induced reorganization of the endocrine pancreas. Since clusterin expression is up-regulated in α cells, but not in β cells undergoing degeneration, it may play a protective role against the cytotoxic insult.

Original languageEnglish
Pages (from-to)57-65
Number of pages9
JournalJournal of Endocrinology
Volume162
Issue number1
DOIs
Publication statusPublished - 1999 Jul 28

Fingerprint

Clusterin
Streptozocin
Islets of Langerhans
Up-Regulation
Injections
Endocrine Cells
Glucagon
Embryonic Development
Cell Death
Glucagon-Secreting Cells
Immunoelectron Microscopy
Secretory Vesicles
Hyperglycemia
Glycoproteins

ASJC Scopus subject areas

  • Endocrinology

Cite this

Up-regulation of clusterin (sulfated glycoprotein-2) in pancreatic islet cells upon streptozotocin injection to rats. / Park, I. S.; Che, Y. Z.; Bendayan, M.; Kang, S. W.; Min, Bon Hong.

In: Journal of Endocrinology, Vol. 162, No. 1, 28.07.1999, p. 57-65.

Research output: Contribution to journalArticle

@article{77418d736fa841bfbeaf96e03493adda,
title = "Up-regulation of clusterin (sulfated glycoprotein-2) in pancreatic islet cells upon streptozotocin injection to rats",
abstract = "Clusterin is a heterodimeric glycoprotein which has been shown to play important roles in programmed cell death and/or in tissue reorganization not only during embryonic development but also in damaged tissues. Recently, we reported the transient induction of clusterin in pancreatic endocrine cells during early developmental stages of islet formation. In the present study, we have investigated the expression of clusterin in pancreatic tissue of streptozotocin-treated rats which were undergoing extensive islet tissue reorganization due to degeneration of insulin β cells. Clusterin was found in endocrine cells identified as glucagon-secreting α cells at the periphery of the islet. Using immunoelectron microscopy, clusterin-positive cells showed the typical ultrastructural features of pancreatic α cells. In addition, colocalization of clusterin and glucagon in the same secretory granules was shown by double immunogold labeling. These results imply that clusterin is a secretory molecule having endocrine and/or paracrine actions in parallel with glucagon. Further, we noted that clusterin expression was increased in pancreatic α cells during the process of β cell death upon streptozotocin injection. The increase was significant as early as 1-3 h after streptozotocin treatment prior to any morphological alteration of islet β cell and any manifestation of hyperglycemia. The expression of clusterin was steady-stately up-regulated during the process of islet reorganization caused by streptozotocin-induced cytotoxic injury. Therefore, we suggest that clusterin might be considered as a molecule induced by both embryonic development and drug-induced reorganization of the endocrine pancreas. Since clusterin expression is up-regulated in α cells, but not in β cells undergoing degeneration, it may play a protective role against the cytotoxic insult.",
author = "Park, {I. S.} and Che, {Y. Z.} and M. Bendayan and Kang, {S. W.} and Min, {Bon Hong}",
year = "1999",
month = "7",
day = "28",
doi = "10.1677/joe.0.1620057",
language = "English",
volume = "162",
pages = "57--65",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "1",

}

TY - JOUR

T1 - Up-regulation of clusterin (sulfated glycoprotein-2) in pancreatic islet cells upon streptozotocin injection to rats

AU - Park, I. S.

AU - Che, Y. Z.

AU - Bendayan, M.

AU - Kang, S. W.

AU - Min, Bon Hong

PY - 1999/7/28

Y1 - 1999/7/28

N2 - Clusterin is a heterodimeric glycoprotein which has been shown to play important roles in programmed cell death and/or in tissue reorganization not only during embryonic development but also in damaged tissues. Recently, we reported the transient induction of clusterin in pancreatic endocrine cells during early developmental stages of islet formation. In the present study, we have investigated the expression of clusterin in pancreatic tissue of streptozotocin-treated rats which were undergoing extensive islet tissue reorganization due to degeneration of insulin β cells. Clusterin was found in endocrine cells identified as glucagon-secreting α cells at the periphery of the islet. Using immunoelectron microscopy, clusterin-positive cells showed the typical ultrastructural features of pancreatic α cells. In addition, colocalization of clusterin and glucagon in the same secretory granules was shown by double immunogold labeling. These results imply that clusterin is a secretory molecule having endocrine and/or paracrine actions in parallel with glucagon. Further, we noted that clusterin expression was increased in pancreatic α cells during the process of β cell death upon streptozotocin injection. The increase was significant as early as 1-3 h after streptozotocin treatment prior to any morphological alteration of islet β cell and any manifestation of hyperglycemia. The expression of clusterin was steady-stately up-regulated during the process of islet reorganization caused by streptozotocin-induced cytotoxic injury. Therefore, we suggest that clusterin might be considered as a molecule induced by both embryonic development and drug-induced reorganization of the endocrine pancreas. Since clusterin expression is up-regulated in α cells, but not in β cells undergoing degeneration, it may play a protective role against the cytotoxic insult.

AB - Clusterin is a heterodimeric glycoprotein which has been shown to play important roles in programmed cell death and/or in tissue reorganization not only during embryonic development but also in damaged tissues. Recently, we reported the transient induction of clusterin in pancreatic endocrine cells during early developmental stages of islet formation. In the present study, we have investigated the expression of clusterin in pancreatic tissue of streptozotocin-treated rats which were undergoing extensive islet tissue reorganization due to degeneration of insulin β cells. Clusterin was found in endocrine cells identified as glucagon-secreting α cells at the periphery of the islet. Using immunoelectron microscopy, clusterin-positive cells showed the typical ultrastructural features of pancreatic α cells. In addition, colocalization of clusterin and glucagon in the same secretory granules was shown by double immunogold labeling. These results imply that clusterin is a secretory molecule having endocrine and/or paracrine actions in parallel with glucagon. Further, we noted that clusterin expression was increased in pancreatic α cells during the process of β cell death upon streptozotocin injection. The increase was significant as early as 1-3 h after streptozotocin treatment prior to any morphological alteration of islet β cell and any manifestation of hyperglycemia. The expression of clusterin was steady-stately up-regulated during the process of islet reorganization caused by streptozotocin-induced cytotoxic injury. Therefore, we suggest that clusterin might be considered as a molecule induced by both embryonic development and drug-induced reorganization of the endocrine pancreas. Since clusterin expression is up-regulated in α cells, but not in β cells undergoing degeneration, it may play a protective role against the cytotoxic insult.

UR - http://www.scopus.com/inward/record.url?scp=0032808895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032808895&partnerID=8YFLogxK

U2 - 10.1677/joe.0.1620057

DO - 10.1677/joe.0.1620057

M3 - Article

C2 - 10396021

AN - SCOPUS:0032808895

VL - 162

SP - 57

EP - 65

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 1

ER -